KEQU Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
71.4M
+2.9%
69.4M
-1.0%
70.1M
-1.4%
71.1M
-7.8%
77.1M
Cost of Revenue
50.2M
-1.4%
50.9M
+0.9%
50.4M
+0.4%
50.2M
-5.5%
53.1M
Gross Profit
21.2M
+14.6%
18.5M
-6.0%
19.7M
-5.8%
20.9M
-12.9%
24.0M
Operating Expenses
16.0M
+0.4%
16.0M
+2.2%
15.6M
-3.1%
16.1M
+3.7%
15.5M
R&D
0
0
0
0
0
SG&A
0
0
0
0
0
Operating Income
5.2M
+102.0%
2.6M
-37.1%
4.1M
-14.6%
4.8M
-43.4%
8.5M
EBITDA
7.3M
+75.6%
4.2M
-26.5%
5.7M
-10.6%
6.4M
-38.2%
10.3M
Net Income
3.7M
+243.1%
1.1M
-57.6%
2.5M
-19.7%
3.2M
-36.1%
4.9M
EPS (Basic)
$1.18
+391.7%
$0.24
-71.8%
$0.85
-21.3%
$1.08
-36.5%
$1.70
EPS (Diluted)
$1.13
+391.3%
$0.23
-72.0%
$0.82
-21.2%
$1.04
-36.2%
$1.63
Shares (Diluted)
3.0M
+0.4%
3.0M
-0.2%
3.0M
+0.9%
3.0M
-0.6%
3.0M
Kewaunee Scientific (KEQU) โ€” Financials